Aesthetics Innovators Podcast

What Investors Are Looking For is the theme of this month’s podcast. It is a panel discussion from the top people and firms who have a track record of successful investments in aesthetics recorded live during this year's Aesthetics Innovation Summit. The panelist include Craig Drill, President of Craig Drill Capital; Adele C. Oliva, Founding Partner at 1315 Capital; Irina Erenburg, CEO & President of Blossom Innovations and Bob Rhatigan, CEO of Merz Americas. It is moderated by AIS Co-Chair Josh Makower, General Partner of NEA Capital and Founder of ExploraMed.Participants:Craig Drill, President - Craig Drill CapitalIrina Erenburg, CEO & President - Blossom InnovationsAdele C. Oliva, Founding Partner - 1315 CapitalBob Rhatigan, CEO - Merz AmericasModerated By:Josh Makower, MD, General Partner - NEA / Executive Chairman - ExploraMed

Executives from the top toxin brands weigh in on the media response to the launch of Jeuveau. This months podcast was a live recording of the Toxin Titans Part II panel from the recent Aesthetics Innovation Summit. Dr Grant Stevens led the discussion on the risk of price erosion and commoditization as competitors enter the market. Listen in to gain perspectives on how these leaders plan to grow and differentiate themselves in a massive market that is still considered untapped.Participants:Dan Browne, CEO & President - Revance Therapeutics Alisa Lask, VP & General Manager, US Aesthetic - Nestlé Skin Health (Galderma) David Moatazedi, President & CEO - Evolus Bob Rhatigan, CEO - Merz Americas Carrie Strom, SVP, Medical Aesthetics - AllerganModerated By:W. Grant Stevens, MD, FACS, CEO - Marina Plastic Surgery/Chief Medical Officer & Co-Founder – OrangeTwist /Clinical Professor - USC School of Medicine

In this episode of the Aesthetics Innovator’s Podcast, physicians Simeon Wall, Jr., MD and Lou Bucky, MD join Co-Host Grant Stevens, MD to discuss the role of physicians in creating new therapies for their patients. The three Aesthetics leaders also evaluate the impact of new toxins in the market as well as other new technologies and approaches that will impact physician aesthetic practices, including Microneedling, innovative patient financing, and partnership with industry. Dr. Wall also shares how the Aesthetics Innovation Summit breaks down barriers to further create physician and industry partnerships. All three physicians will be speaking at the upcoming Aesthetics Innovation Summit on May 15th in New Orleans.

Aubrey Rankin, CEO and President of HintMD shares how the young start-up’s path of discovery has created a dynamic platform that solves a key problem for doctors. Aubrey gives insight into their pivot to help undertreated patients in the market. Aubrey also reveals their latest data results, industry trends towards subscriptions and how their technology manages the complexities in membership programs in aesthetics.Rankin also gives us details about his unique background - from growing up in South Africa, to a key role at Zeltiq leading Asia Pacific commercial sales and eventually, to his current role as CEO. Rankin is a featured speaker at our upcoming Aesthetics Innovation Summit on May 15th in New Orleans. Attend AIS – a one-day gathering of the professionals driving the most dynamic sector in healthcare.

In this Aesthetics Innovators Podcast episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also discusses several of the company’s effective marketing plans to target “Reclaimers” and to tout the effectiveness of skin-tightening tool Ultherapy with a campaign highlighting Christie Brinkley. Rhatigan will be pulling double duty at the upcoming Aesthetics Innovation Summit, sitting on our panels, “Clash of the Toxin Titans, Part II” and “What Investors Are Looking for in Aesthetics.” In this interview, Rhatigan discusses Merz’s in-house venture program. “We don’t just want to provide seed money,” he says. “We want to provide intellectual value.” Speaking of the May 15 Aesthetics Innovation Summit, Rhatigan says he’s excited by the potential networking opportunities based on last year’s successful event. “We’ve got the physician base there. Industry is there. The investment capital folks are there,” he says. "For us in medical aesthetics, innovation really stems from strong collaboration and communication.”

William Meury, EVP, and chief commercial officer, a keynote speaker at the upcoming Aesthetics Innovation Summit, talks shop with AI Podcast co-host Grant Stevens, MD. In this conversation at Dr. Stevens’ office in Marina Del Rey, CA, the two aesthetics leaders swap insights on the meteoric growth of the aesthetics industry driven in large part by the surging millennial market. Meury also dishes on Allergan’s M&A strategy including the fast-acting neurotoxins developed by recently acquired Bonti. And he gives his assessment of the emerging competition for Allergan’s anchor product, Botox. Plus, why is Allergan building an Aesthetics Innovation center in China?

In this month's podcast David Moatazedi joins host Grant Stevens, MD to discuss the latest developments at Evolus, his new role as CEO and how doctors are involved with the company as they prepare for commercialization in 2019. David shares insight into their plans, an in-depth review of Evolus, its new management team and its competitive advantages. He also answers several questions that are on the top of many of our minds. Don't miss out and listen today.

In this podcast, AIS Co-Chair Mark Foley - a successful executive in his own right - asks Dan Browne, CEO of Revance Therapeutics several compelling questions.How did his love for the outdoors lead to his career in medical technology? What led him to co-found Revance with two friends? What were some of the important “pivot points” in building this exciting aesthetics company? What’s next for Revance following last week’s exciting news about its long-acting neuromodulator DaxibotulinumtoxinA for Injection (RT002).

Welcome to the Aesthetics Innovators Podcast. In this episode, host Grant Stevens, MD, the founder and medical director of Marina Plastic Surgery and The Orange Twist Institute, discusses the future of aesthetics innovation with Mark Foley, the former CEO of Zeltiq. Dr. Stevens, Foley, and Josh Makower, MD, general partner at NEA, serve as co-chairs of the Aesthetics Innovation Summit, which will take place on May 15 in New Orleans prior to the ASAP’s annual meeting.